Search Results 381-390 of 16982 for pharmacogenetics
This study is being done to gather information regarding your health in relation to your composite tissue transplant. We would like to use your medical records ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
About this study. The purpose of this study is to analyze and report orbital decompression outcomes in patients with a thyroid eye disease diagnosis.
View clinical trials, clinical studies and funding information for Mayo Clinic's Genomic and Exposomic Hepatobiology Lab led by Konstantinos N. Lazaridis, ...
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in ...
View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
The Biliary Epigenetics and Regenerative Medicine Laboratory of Robert C. Huebert, M.D., at Mayo Clinic provides training, education and career ...
The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.